Clinical Trials Browser

Gastric Adenocarcinoma × pembrolizumab × Gastrointestinal × Clear all

NCT04164979 2025-08-11

Ph II Study of Cabozantinib With Pembrolizumab in Metastatic Gastric and Gastroesophageal Adenocarcinoma

Phase 2 Active not recruiting

34 enrolled 11 charts

Gastrointestinal

Gastric Adenocarcinoma